Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Nuclear Imaging Agents Market Report Overview
The nuclear imaging agents market size was $988 million in 2023 and will grow at a CAGR of more than 2% from 2023 to 2033. Nuclear imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases.
Nuclear Imaging Agents Market Outlook 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Nuclear Imaging Agents Market Forecast, Download a Free Sample Report
The nuclear imaging agents market research report identifies quantitative market trends within cardiovascular devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the nuclear imaging agents market for 2020 and beyond. Furthermore, the report provides nuclear imaging agents’ market share by a company that will help in identifying untapped market opportunities.
Market Size (2023) | $988 million |
CAGR (2023-2033) | >2% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments | · PET Imaging Agents
o Copper-Based PET Imaging Agents o Fluorine-Based PET Imaging Agents o Gallium-68-Based PET Imaging Agents o Rubidium-Based PET Imaging Agents · SPECT Imaging Agents o Gallium-67-Based SPECT Imaging Agents o Indium-Based SPECT Imaging Agents o Iodine-Based SPECT Imaging Agents o Lutetium-Based SPECT Imaging Agents o Technetium-Based SPECT Imaging Agents o Thallium-Based SPECT Imaging Agents |
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Nuclear Imaging Agents Market Segments
The key segments in the nuclear imaging agents market are PET imaging agents and SPECT imaging agents. In 2023, the SPECT imaging agents segment accounted for the highest share of the market. Gallium-67-Based SPECT imaging agents, Indium-Based SPECT imaging agents, Iodine-Based SPECT imaging agents, Lutetium-Based SPECT imaging agents, Technetium-Based SPECT imaging agents, and Thallium-Based SPECT imaging agents are the sub-categories of the leading segment.
SPECT imaging agents are compounds that contain a small amount of material that emits radiation, called radiotracers. They are introduced into the body typically via injection. They accumulate areas and can then be detected by SPECT molecular imaging cameras to help provide a detailed image of what is happening inside that area of the body.
Nuclear Imaging Agents Market Analysis by Segments, 2023 (%)
Buy the Full Report for more Segment-Wise Insights into the Nuclear Imaging Agents Market,
Download a Free Sample Report
Nuclear Imaging Agents Market Segmentation by Regions
The key regions in the nuclear imaging agents market are Asia-Pacific, Europe, the Middle East, and Africa. North America and South and Central America are other leading regional markets. In 2023, the North American nuclear imaging agents market was the leading regional market.
Advancements in research and technology better access to healthcare facilities, availability of skilled professionals, better patient awareness, and improved health insurance policies are driving the North American nuclear imaging agents market growth. The US market mainly drives the North American market.
Nuclear Imaging Agents Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Nuclear Imaging Agents Market, Download a Free Sample Report
Nuclear Imaging Agents Market – Competitive Landscape
In 2023, GE HealthCare Technologies Inc. accounted for the highest share of the nuclear imaging agents market
The major players in the nuclear imaging agents market are:
- Cardinal Health Inc
- GE HealthCare Technologies Inc
- Novartis AG
- Bracco Imaging SpA
- Lantheus Holdings Inc
GE HealthCare Technologies Inc leads the market by delivering innovative and sustainable solutions to improve the quality of life for their customers. Aging populations, increasing chronic and lifestyle-related diseases, accelerating demand for healthcare in emerging markets, and the increasing use of diagnostics and monitoring in patient care continue to fuel demand for GE’s offerings.
Nuclear Imaging Agents Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Nuclear Imaging Agents Market, Download a Free Sample Report
Nuclear Imaging Agents Market Dynamics
- Drivers: The key factors positively impacting the nuclear imaging agents market are unhealthy and sedentary lifestyles leading to chronic ailments and cancer, betterment of healthcare facilities, and advancement in research and technology.
- Barriers: Factors such as the risk of radiation exposure, the high cost of equipment, and a lack of technical advancement in remote areas may affect the demand for nuclear imaging agents
- Future Outlook: Global Data expects an increase in the nuclear imaging market in the forecast period. However, PET systems may not be replaced by SPECT systems even if they are cheap and technically advancing because PET systems give better-resolution images with less scatter and attenuation. The half-life of radiotracer is six hours which further increases the time of imaging. Unlike PET systems, SPECT systems produce qualitative images which can be uncertain.
Purchase the Complete Report for Additional Insights on the Nuclear Imaging Agents Market Dynamics, Get a Free Sample Report Here
Segments Covered in this Report
Nuclear Imaging Agents Segment Outlook ($ Million, 2015-2033)
- PET Imaging Agents
- Copper-Based PET Imaging Agents
- Fluorine-Based PET Imaging Agents
- Gallium-68-Based PET Imaging Agents
- Rubidium-Based PET Imaging Agents
- SPECT Imaging Agents
- Gallium-67-Based SPECT Imaging Agents
- Indium-Based SPECT Imaging Agents
- Iodine-Based SPECT Imaging Agents
- Lutetium-Based SPECT Imaging Agents
- Technetium-Based SPECT Imaging Agents
- Thallium-Based SPECT Imaging Agents
Nuclear Imaging Agents Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
The nuclear imaging agents market research report includes an insightful review of the key industry trends.
- The nuclear imaging agents market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global nuclear imaging agents market insights:
- The nuclear imaging agents market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Nuclear imaging agents market SWOT analysis.
- The report provides trends and nuclear imaging agents’ market competitive dynamics.
Buy the Full Report for More Insights on the Nuclear Imaging Agents Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered: Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications SA, Bracco Diagnostics Inc., Lantheus Holdings Inc., and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the nuclear imaging agents market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the nuclear imaging agents market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the impact of COVID-19 on the nuclear imaging agents market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the nuclear imaging agents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the nuclear imaging agents market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of nuclear imaging agents’ market share by company. Identify strong competitors and create winning strategies to stand out in the global nuclear imaging agents market.
- Track device sales in the global and country-specific Nuclear Imaging Agents market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
GE Healthcare
Advanced Accelerator Applications SA
Bracco Diagnostics Inc
Lantheus Holdings Inc
Others
Frequently asked questions
-
What was the nuclear imaging agents' market size in 2023?
The size of the nuclear imaging agents market was $988 million in 2023.
-
What will the CAGR of the nuclear imaging agents market be during the forecast period?
The nuclear imaging agents market will grow at a CAGR of more than 2% during 2023-2033.
-
Which region held the largest share of the nuclear imaging agents market in 2023?
North America was the largest regional market for nuclear imaging agents in 2023.
-
Which are the leading players in the nuclear imaging agents market?
A few of the leading nuclear imaging agents market companies are Cardinal Health Inc., GE HealthCare Technologies Inc., Novartis AG, Bracco Imaging SpA, and Lantheus Holdings Inc. among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.